Loading…

A Comparative Study Between Labeling and Reality: The Case of Phytochemical Composition of Commercial Pomegranate‐Based Products

Manufacturers are deeply involved in the development of new pomegranate‐based products, which have acquired great prestige due to many studies proving their potential health benefits. Commercial pomegranate products including capsules and supplements and juices and nectars were assayed. The contents...

Full description

Saved in:
Bibliographic Details
Published in:Journal of food science 2017-08, Vol.82 (8), p.1820-1826
Main Authors: Cano‐Lamadrid, Marina, Lipan, Leontina, Calín‐Sánchez, Ángel, Hernández, Francisca, Carbonell‐Barrachina, Ángel A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Manufacturers are deeply involved in the development of new pomegranate‐based products, which have acquired great prestige due to many studies proving their potential health benefits. Commercial pomegranate products including capsules and supplements and juices and nectars were assayed. The contents of the key phytochemical compounds (punicalagin, ellagic acid, and total polyphenolic content) and the associated antioxidant capacity (DPPH•, ABTS•+, and FRAP) were analyzed. The experimental ranges of punicalagin and ellagic acid contents were 0.96 to 308 mg/g and 0.09 to 13.1 mg/g, respectively. Punicalagin content was positively correlated (P  0.05) correlation was observed among ellagic acid with the antioxidant capacity. The labeling standardization of these products is necessary due to the wide variability among “theoretically” similar pomegranate‐based products. Practical Application There is a need for labeling “standardization” of these products due to the wide variability of the key compounds (punicalagins, ellagic acid, and the total polyphenolic compounds) among “theoretically” similar pomegranate‐based products. The contents of the key compounds should be declared on product labels, as indicators of the potential health benefits, and should replace subjective functional descriptions.
ISSN:0022-1147
1750-3841
DOI:10.1111/1750-3841.13788